Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Originally developed to help manage type 2 diabetes, certain GLP-1 medications are now also used to support weight loss in suitable patients living with obesity or other weight-related health conditions
Synoradzki, R
Notably, Wegovy the name-brand version of the weight loss injectable, which uses the glucagon-like peptide-1 receptor agonists known as semaglutide to mimic the stomachs feeling of fullness is only available in six countries (though to be fair, the oral pill Rybelsus that uses the same active ingredient is very much for sale in India.) With Novo predicting that it may be two years or more before it comes to the country, drugmakers there are looking to get in on the action while the market is still hot
Tips to identify red flags Talk to your healthcare prescriber and see if they recommend a compounding pharmacy
